Nifty
Sensex
:
:
10482.20
34812.99
-103.00 (-0.97%)
-345.56 (-0.98%)

Pharmaceuticals & Drugs

Rating :
78/99

BSE: 500660 | NSE: GLAXO

1398.10
-22.05 (-1.55%)
12-Nov-2018 | 3:57PM
  • Day's Open
  • Day's High
  • Day's Low
  • Previous Close
  •  1408.30
  •  1429.90
  •  1380.50
  •  1420.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  8944
  •  125.05
  •  1800.05
  •  1010.00

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 24,156.45
  • 62.81
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 22,861.03
  • 1.23%
  • 12.63

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 75.00%
  • 0.55%
  • 10.98%
  • FII
  • DII
  • Others
  • 8.2%
  • 2.71%
  • 2.56%

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 0.53

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • 1.30

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • -
  • -2.05

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 52.26
  • 66.98
  • 67.79

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 10.83
  • 12.16
  • 12.36

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 30.62
  • 38.64
  • 41.53

Quarterly Results

Standalone Figures in Rs. Crores /

Consolidated
Description
Jun 18
Jun 17
Var%
Mar 18
Mar 17
Var%
Dec 17
Dec 16
Var%
Sep 17
Sep 16
Var%
Net Sales
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBITDA
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
EBIDTM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
Other Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Depreciation
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PBT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PATM
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
0.00%
EPS
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Dec 08
Net Sales
-
2,871.45
2,908.47
2,837.91
3,362.91
2,607.70
2,692.06
2,455.38
2,151.06
1,907.77
1,693.41
Net Sales Growth
-
-1.27%
2.49%
-15.61%
28.96%
-3.13%
9.64%
14.15%
12.75%
12.66%
 
Cost Of Goods Sold
-
1,241.31
1,397.75
1,324.90
1,327.66
1,171.68
1,100.57
923.50
785.73
700.01
650.18
Gross Profit
-
1,630.14
1,510.72
1,513.02
2,035.25
1,436.02
1,591.49
1,531.87
1,365.33
1,207.75
1,043.23
GP Margin
-
56.77%
51.94%
53.31%
60.52%
55.07%
59.12%
62.39%
63.47%
63.31%
61.61%
Total Expenditure
-
2,365.66
2,489.49
2,359.64
2,788.33
2,124.49
1,915.22
1,693.90
1,478.25
1,324.67
1,164.91
Power & Fuel Cost
-
26.44
27.82
25.97
31.17
23.85
22.50
26.70
26.75
24.66
24.75
% Of Sales
-
0.92%
0.96%
0.92%
0.93%
0.91%
0.84%
1.09%
1.24%
1.29%
1.46%
Employee Cost
-
523.40
483.01
443.37
493.02
362.05
295.52
278.36
234.53
203.97
168.36
% Of Sales
-
18.23%
16.61%
15.62%
14.66%
13.88%
10.98%
11.34%
10.90%
10.69%
9.94%
Manufacturing Exp.
-
110.55
108.26
118.09
367.24
127.78
113.62
111.44
67.51
60.08
52.65
% Of Sales
-
3.85%
3.72%
4.16%
10.92%
4.90%
4.22%
4.54%
3.14%
3.15%
3.11%
General & Admin Exp.
-
203.53
195.08
154.85
178.21
135.34
126.10
108.51
145.09
130.13
116.13
% Of Sales
-
7.09%
6.71%
5.46%
5.30%
5.19%
4.68%
4.42%
6.75%
6.82%
6.86%
Selling & Distn. Exp.
-
154.38
178.91
164.47
222.31
186.23
160.74
157.60
140.85
131.33
96.06
% Of Sales
-
5.38%
6.15%
5.80%
6.61%
7.14%
5.97%
6.42%
6.55%
6.88%
5.67%
Miscellaneous Exp.
-
106.05
98.67
127.99
168.72
117.55
96.17
87.78
72.33
73.30
96.06
% Of Sales
-
3.69%
3.39%
4.51%
5.02%
4.51%
3.57%
3.58%
3.36%
3.84%
3.58%
EBITDA
-
505.79
418.98
478.27
574.58
483.21
776.84
761.48
672.81
583.10
528.50
EBITDA Margin
-
17.61%
14.41%
16.85%
17.09%
18.53%
28.86%
31.01%
31.28%
30.56%
31.21%
Other Income
-
54.54
73.07
123.18
258.80
222.30
223.90
186.59
217.06
194.80
189.37
Interest
-
0.19
0.25
0.42
0.47
0.33
0.33
0.33
0.62
0.37
0.53
Depreciation
-
37.99
26.35
24.95
25.35
19.88
17.84
20.41
17.63
16.37
16.34
PBT
-
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
761.16
701.01
Tax
-
189.24
174.37
202.25
279.27
229.78
272.48
176.20
293.35
260.70
238.14
Tax Rate
-
35.05%
34.11%
34.97%
36.96%
32.30%
32.66%
29.13%
33.66%
34.25%
33.97%
PAT
-
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
500.46
462.87
PAT before Minority Interest
-
350.73
336.81
376.14
476.41
481.67
561.88
428.59
578.27
500.46
462.87
Minority Interest
-
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
-
12.21%
11.58%
13.25%
14.17%
18.47%
20.87%
17.46%
26.88%
26.23%
27.33%
PAT Growth
-
4.13%
-10.46%
-21.05%
-1.09%
-14.28%
31.10%
-25.88%
15.55%
8.12%
 
Unadjusted EPS
-
41.41
39.76
44.41
56.24
56.87
66.34
50.60
66.18
59.96
69.78

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Dec 08
Shareholder's Funds
2,057.33
2,006.86
2,183.25
1,828.98
1,989.73
2,006.83
1,935.70
1,951.58
1,786.09
1,575.53
Share Capital
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
84.70
Total Reserves
1,972.63
1,922.15
2,098.55
1,744.28
1,905.03
1,922.13
1,851.00
1,866.88
1,701.39
1,490.83
Non-Current Liabilities
2,632.47
3,699.70
3,498.32
197.04
158.59
158.45
172.78
-51.43
-39.47
-24.13
Secured Loans
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Unsecured Loans
0.58
0.99
1.60
2.63
3.61
4.14
4.59
5.16
5.42
5.65
Long Term Provisions
2,733.36
3,786.83
3,592.19
272.21
242.29
236.05
224.81
0.00
0.00
0.00
Current Liabilities
1,599.86
720.23
783.63
1,106.55
888.91
836.40
859.59
3,179.07
2,718.89
2,510.11
Trade Payables
505.86
278.93
327.74
308.04
285.63
237.37
200.58
334.36
294.42
255.08
Other Current Liabilities
842.35
390.47
202.82
130.09
84.13
86.82
67.25
12.60
22.78
20.65
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
251.66
50.83
253.08
668.42
519.15
512.21
591.77
2,832.12
2,401.69
2,234.38
Total Liabilities
6,289.66
6,426.79
6,465.20
3,132.57
3,037.23
3,001.68
2,968.07
5,079.22
4,465.51
4,061.51
Net Block
322.81
252.71
204.04
123.08
100.09
89.42
99.15
108.95
92.83
90.42
Gross Block
405.89
299.09
228.36
363.34
343.22
316.18
315.80
362.54
333.32
326.29
Accumulated Depreciation
83.08
46.38
24.32
240.26
243.13
226.76
216.65
253.59
240.49
235.87
Non Current Assets
4,103.26
4,752.54
4,087.05
545.58
413.30
355.01
363.01
235.57
262.64
751.21
Capital Work in Progress
922.90
605.46
267.67
115.22
61.86
43.79
16.19
8.72
21.36
9.95
Non Current Investment
1.84
5.40
6.04
0.06
0.06
10.06
54.98
117.90
148.46
650.84
Long Term Loans & Adv.
2,855.66
3,888.91
3,609.24
296.09
237.73
194.55
157.01
0.00
0.00
0.00
Other Non Current Assets
0.06
0.06
0.06
11.13
13.55
17.19
35.68
0.00
0.00
0.00
Current Assets
2,186.41
1,674.25
2,378.15
2,586.98
2,623.94
2,646.67
2,605.06
4,843.65
4,202.88
3,310.30
Current Investments
0.00
0.00
0.00
0.00
10.00
44.91
57.21
0.00
0.00
78.68
Inventories
500.18
425.80
525.87
375.58
346.97
285.15
333.44
285.55
257.30
232.98
Sundry Debtors
146.96
170.80
126.56
100.32
96.39
115.90
85.31
47.03
53.73
57.94
Cash & Bank
1,296.41
899.61
1,391.90
1,910.61
2,041.58
2,066.77
2,014.36
2,002.89
1,733.90
956.73
Other Current Assets
242.86
52.27
23.24
88.43
128.99
133.94
114.74
2,508.18
2,157.95
1,983.97
Short Term Loans & Adv.
199.52
125.77
310.58
112.04
71.19
58.18
50.12
2,454.34
2,127.55
1,938.04
Net Current Assets
586.54
954.01
1,594.52
1,480.43
1,735.03
1,810.27
1,745.46
1,664.58
1,483.98
800.18
Total Assets
6,289.67
6,426.79
6,465.20
3,132.56
3,037.24
3,001.68
2,968.07
5,079.22
4,465.52
4,061.51

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Dec 08
Cash From Operating Activity
472.80
234.37
138.90
337.64
281.31
313.59
335.37
479.36
511.51
330.03
PBT
522.17
465.46
576.08
807.56
685.30
982.58
927.33
871.62
761.16
701.01
Adjustment
-12.17
-46.47
-96.01
-173.66
-156.37
-159.63
-139.38
-89.96
-69.78
-86.93
Changes in Working Capital
164.56
-26.69
-124.41
-36.90
11.45
56.35
-73.09
12.66
20.47
-32.57
Cash after chg. in Working capital
674.55
392.29
355.67
597.00
540.37
879.30
714.86
794.32
711.85
581.51
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
-202.01
-160.59
-205.95
-252.43
-244.09
-318.38
-316.53
-313.89
-185.38
-246.43
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.25
2.67
-10.82
-6.93
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-104.19
300.64
499.02
180.01
188.98
-109.65
358.03
86.76
660.78
826.92
Net Fixed Assets
-424.24
-408.52
-61.62
-73.47
-45.11
-27.98
39.27
-16.58
-18.44
-19.96
Net Investments
3.56
0.64
-5.96
10.00
44.92
57.21
0.55
30.56
560.97
581.44
Others
316.49
708.52
566.60
243.48
189.17
-138.88
318.21
72.78
118.25
265.44
Cash from Financing Activity
-306.63
-510.76
-638.33
-496.99
-494.14
-440.63
-394.81
-297.15
-394.84
-355.34
Net Cash Inflow / Outflow
61.97
24.24
-0.42
20.66
-23.85
-236.69
298.59
268.97
777.45
801.61
Opening Cash & Equivalents
139.13
114.89
115.30
94.93
137.67
374.36
75.77
1,734.03
956.58
154.97
Closing Cash & Equivalent
201.10
139.13
114.89
115.59
113.82
137.67
374.36
2,003.01
1,734.03
956.58

Financial Ratios

Consolidated /

Standalone
Description
Mar 18
Mar 17
Mar 16
Mar 15
Dec 13
Dec 12
Dec 11
Dec 10
Dec 09
Dec 08
Book Value (Rs.)
121.44
118.46
128.88
107.96
117.45
118.46
114.26
115.20
105.43
93.00
ROA
5.52%
5.23%
7.84%
15.44%
15.95%
18.82%
10.65%
12.12%
11.74%
12.17%
ROE
17.26%
16.08%
18.75%
24.95%
24.10%
28.50%
22.05%
30.94%
29.77%
31.31%
ROCE
26.56%
24.39%
28.82%
39.53%
35.54%
42.24%
31.05%
46.54%
45.16%
47.28%
Fixed Asset Turnover
8.21
11.38
9.59
9.82
8.13
8.74
7.40
6.31
5.91
5.61
Receivable days
20.03
18.09
14.59
10.35
14.45
13.29
9.62
8.38
10.45
9.77
Inventory Days
58.36
57.89
57.97
38.01
43.02
40.86
45.01
45.13
45.88
45.36
Payable days
66.11
51.51
53.81
43.72
49.18
47.40
62.14
88.58
85.41
86.80
Cash Conversion Cycle
12.28
24.47
18.75
4.64
8.28
6.75
-7.51
-35.07
-29.09
-31.66
Total Debt/Equity
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Interest Cover
2856.45
2045.74
1373.88
1612.26
2146.51
2497.59
1848.25
1403.44
2037.83
1334.73

News Update:


  • GlaxoSmithKline Pharmaceuticals reports 23% fall in Q2 net profit
    22nd Oct 2018, 14:22 PM

    Total income from operations of the company marginally decreased by 1.74% at Rs 831.13 crore

    Read More
  • Glaxosmithkline Phar - Quarterly Results
    22nd Oct 2018, 13:33 PM

    Read More

Source: www.accordfintech.com. Price feed provided by www.nseindia.com and www.bseindia.com value addition by www.accordfintech.com. Intraday data delayed 15 minutes.

DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.